Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.

Author: BogaardJ M, HegmansJ P J J, HoogstedenH C, MulderP G H, PrinsJ-B, VerhoevenG T

Paper Details 
Original Abstract of the Article :
Treatment of chronic obstructive pulmonary disease (COPD) with inhaled corticosteroids does not appear to be as effective as similar treatment of asthma. It seems that only certain subgroups of patients with COPD benefit from steroid treatment. A study was undertaken to examine whether inhaled fluti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/thorax.57.8.694

データ提供:米国国立医学図書館(NLM)

Fluticasone Propionate for COPD: A Targeted Approach to Treatment

The study of [chronic obstructive pulmonary disease (COPD)] is a quest for effective treatments that can improve the quality of life for individuals struggling with this debilitating lung condition. While [inhaled corticosteroids] have proven effective in treating asthma, their efficacy in COPD has been less clear. This study investigates the effects of inhaled fluticasone propionate (FP) in a specific subgroup of COPD patients—those with [bronchial hyperresponsiveness (BHR)].

Seeking Precision in Treatment: Fluticasone Propionate and Bronchial Hyperresponsiveness

The researchers found that inhaled FP had a positive impact on lung function and markers of inflammation in COPD patients with BHR. This suggests that a targeted approach, focusing on specific subgroups of COPD patients, may hold the key to more effective treatment outcomes.

A Tailored Approach to COPD Management: Identifying Subgroups for Targeted Therapies

This study underscores the importance of identifying specific subgroups of COPD patients who may benefit most from inhaled corticosteroids. This personalized approach to treatment can help maximize the benefits of medication while minimizing potential side effects.

Dr.Camel's Conclusion

Just as a desert traveler navigates different terrains with varying strategies, COPD treatment requires a tailored approach. This study highlights the importance of recognizing the unique characteristics of COPD patients and adapting treatment accordingly. By understanding the nuances of this complex disease, we can better guide individuals towards a path of improved health and well-being.

Date :
  1. Date Completed 2002-09-12
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

12149529

DOI: Digital Object Identifier

10.1136/thorax.57.8.694

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.